semaglutide longevity (Month 1) 0.25mg Semaglutide Treatment | Longevity Direct

Lancet 397(10278):971984 Shi I, Khan SS, Yeh RW, Ho JE, Dahabreh IJ, Kazi DS (2025) Semaglutide Eligibility Across All Current Indications for US Adults

What employers need to know Are you aware of all available rebates for your Rx spend

Real-world studies such as SURMOUNT-REAL, a five-year real-world observational program, are designed to answer questions that randomised trials cannot

Funding is shaped by strong growth potential from subscription models and recurring revenue, balanced against investor scrutiny around regulatory exposure, compounded formulations, pricing pressure, and the need for broader insurance coverage to reach scale